Consolidation of Drug Regulations

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is consolidating a list of drugs, previously determined by rulemaking to be new drugs, into one section. This document also removes the sections now providing for these drugs, except for certain information in the regulations that FDA considers to be necessary. This action, which will make the regulations more concise and efficient, is being taken in response to the President's regulatory reinvention initiative (REGO).

情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →

Consolidation of Drug Regulations

Office of Management and Budget (OMB) に提出された情報収集活動; Food and Drug Administration (FDA) の提出書類の提出; Customer/Partner Customer Service Satisfaction Surveys に関するコメントの要求

Agency Information Collection Activities: Proposed Collection; Comment Request

Office of the National Coordinator for Health Information Technology; Health Information Technology Advisory Committee; エンタイントにそすにしたプログルにしたプログにプログを定义にしたプログに。